Literature DB >> 1530073

Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene.

W M Grove1, B A Clementz, W G Iacono, J Katsanis.   

Abstract

OBJECTIVE: Evidence suggests that poor eye tracking relates to genetically transmitted vulnerability for schizophrenia. The authors tested competing models for the genetic transmission of poor eye tracking in a search for major gene effects.
METHOD: Samples from three studies (conducted in Minneapolis, New York, and Vancouver, B.C.) were pooled. Probands (N = 92) were diagnosed as schizophrenic by DSM-III criteria. Of the comparison subjects (N = 171), Vancouver patients were an epidemiologic first-episode group; at other sites unselected admitted patients were studied. First-degree relatives (N = 146) of 65 probands were also studied. Eye tracking was measured while subjects followed a horizontally moving, sinusoidally driven (0.4 Hz) spot of light on a screen. Performance was quantified by root mean square error. Data analysis was by complex segregation analysis (Bonney's class D regressive models).
RESULTS: A single major gene is needed to account for poor eye tracking in schizophrenic patients and their relatives. This gene alone can explain about two-thirds of the variance in eye tracking performance. A single gene alone (regardless of dominance) will, however, not account for the data; polygenic factors are also required.
CONCLUSIONS: Results support postulation of a single gene for ocular motor dysfunction, which may be a risk factor for schizophrenia. Eye tracking may be useful as a gene carrier test in genetic studies of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530073     DOI: 10.1176/ajp.149.10.1362

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  8 in total

1.  A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades.

Authors:  Ilhame Ameqrane; Ameqrane Ilhame; Nicolas Wattiez; Wattiez Nicolas; Pierre Pouget; Pouget Pierre; Marcus Missal; Missal Marcus
Journal:  Psychopharmacology (Berl)       Date:  2015-07-09       Impact factor: 4.530

2.  Eye tracking dysfunction in families with multiple cases of schizophrenia.

Authors:  V Arolt; R Lencer; A Nolte; M Pinnow; E Schwinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

3.  SPEM dysfunction and general schizotypy as measured by the SSQ: a controlled study.

Authors:  Dirk van Kampen; Jan Berend Deijen
Journal:  BMC Neurol       Date:  2009-06-29       Impact factor: 2.474

4.  Refining the predictive pursuit endophenotype in schizophrenia.

Authors:  L Elliot Hong; Kathleen A Turano; Hugh O'Neill; Lei Hao; Ikwunga Wonodi; Robert P McMahon; Amie Elliott; Gunvant K Thaker
Journal:  Biol Psychiatry       Date:  2007-07-30       Impact factor: 13.382

Review 5.  Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.

Authors:  Gunvant K Thaker
Journal:  Schizophr Bull       Date:  2008-05-22       Impact factor: 9.306

6.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

7.  The Role of Biomarkers and Endophenotypes in Prevention and Treatment of Psychopathological Disorders.

Authors:  Theodore P Beauchaine
Journal:  Biomark Med       Date:  2009-02-01       Impact factor: 2.851

Review 8.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.